[The clinico-immunological efficacy of dioxidine in the combined treatment of acute abscessing pneumonias in persons who abuse alcohol].
The results of clinico-immunologic studies of the efficacy of dioxidin in persons abusing alcohol have demonstrated that unlike antibiotics, dioxidin does not provoke any immunosuppressive disorders. It is recommended that dioxidin should be included into multimodality treatment of patients with acute lung abscesses, abusing alcohol.
Nikitin
A V
AV
Simvolokov
S I
SI
Karpukhina
E P
EP
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000428:Alcohol Drinking / Q000187:drug effects / Q000502:physiology*; D000437:Alcoholism / Q000097:blood / Q000150:complications / Q000276:immunology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007109:Immunity / Q000187:drug effects / Q000276:immunology; D015227:Lipid Peroxidation / Q000187:drug effects; D008169:Lung Abscess / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011810:Quinoxalines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D011810:Quinoxalines; C001077:dioxidine
Kliniko-immunologicheskaia éffektivnost' dioksidina v kompleksnom lechenii ostrykh abstsediruiushchikh pnevmoniĭ u lits, zloupotrebliaiushchikh alkogolem.